ROLE OF CEREBROPROTEIN HYDROLYSATE IN OUTCOME AND RECOVERY OF TRAUMATIC BRAIN INJURY
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2018, Vol 7, Issue 18
Abstract
BACKGROUND Traumatic Brain Injury (TBI) is a complex injury with a wide range of symptoms and disabilities, which can lead to a lifelong devastating effect on the patient and the family. Its (TBI) incident is increasing day-by-day. There is a need of better management in traumatic brain injury patient to reduce the mortality and associated with it. Cerebroprotein hydrolysate is a recent neurotrophic and neuroprotective drug which is in use for acute ischaemic strokes, vascular dementia, Alzheimer’s disease and traumatic brain injuries with its proven potential. Aims and Objectives- Our work aims to evaluate the effectiveness and safety of cerebroprotein hydrolysate in the management of brain injury patients. MATERIALS AND METHODS A randomised controlled trial used in the study and the sample size was taken for convenience during the study. This study was conducted on 200 patients and the patients were randomly divided into two groups. Group 1 (study group, n= 100) received cerebroprotein hydrolysate for 14 - 21 days and Group 2 (control group, n= 100) received only conventional therapy. Both the groups were assessed with GCS (Glasgow Coma Score), APACHE Π (Acute Physiology and Chronic Health Evaluation II) scores and CT/ MRI Brain on admission and were compared in terms of degree of improvement on 14 - 21 days from the day of admission. RESULTS Patient on cerebroprotein hydrolysate was compared to conventional therapy (control) group. Patients with cerebroprotein hydrolysate showed statistical significance (p value= 0.001) in regard to GCS and in terms of functional and cognitive outcome. CONCLUSION Our study concludes that the usage of cerebroprotein hydrolysate therapy can be safe and useful in traumatic brain injury in terms of functional and cognitive outcome with better recovery
Authors and Affiliations
Ishwar Dayal Chaurasia, Manish Parihar, Puspendra Gehlot, Ansul Siroliya, Songara M. C
Keywords
Related Articles
- EP ID EP417267
- DOI 10.14260/jemds/2018/489
- Views 63
- Downloads 0
TRANSVERSUS ABDOMINIS PLANE (TAP) BLOCK REDUCES POSTOPERATIVE MORHPINE REQUIRMENT AND POSTOPERATIVE SEDATION SCORES IN PATIENTS UNDERGOING LOWER ABDOMINAL OPERATIONS: A PROSPECTIVE STUDY.
[b] BACKGROUND[/b]: Transversus abdominis plane (TAP) block is a regional anaesthetic technique which has recently gained popularity. It is being used for postoperative analgesia for upper and lower abdominal su...
SPECTRUM OF POSTERIOR CRANIAL FOSSA SPACE OCCUPYING LESIONS- OUR EXPERIENCE AT A TERTIARY CARE CENTRE
BACKGROUND Posterior cranial fossa is located between the Foramen Magnum and Tentorium Cerebelli. It contains cerebellum, pons and medulla oblongata. Tumours of posterior cranial fossa can affect any of the above structu...
ADENOMATOID TUMOR OF TAIL OF EPIDIDYMIS - A CASE REPORT
Paratesticular tumours are rare but generally benign neoplasms, of mesothelial in origin. Adenomatoid tumours of epididymis are uncommon and accounts for 30% of all paratesticular neoplasms. A case of Adenomato...
MIDAZOLAM SYRUP AS A PREMEDICATION IN PAEDIATRIC PATIENTS- A RANDOMISED, DOUBLEBLIND, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY
BACKGROUND Premedication is expedient in reducing the psychological trauma from recalling the unpleasant pre-anaesthetic phases; hence, inducing a trouble-free anaesthesia. Aim- This study was done to evaluate commercial...
A CASE OF INCARCERATED EPIGASTRIC HERNIA IN AN ADULT MALE
PRESENTATION OF CASE A 45-year-old, male patient was admitted to our hospital 3 hours after the sudden onset of abdominal pain. His epigastric region had a swelling and he was diagnosed with an irreducible epigastric her...